Stereotactic Body Radiotherapy and Focal Adhesion Kinase Inhibitor in Advanced Pancreas Adenocarcinoma
Last updated on July 2021Recruitment
- Recruitment Status
- Not yet recruiting
- Estimated Enrollment
- 36
Summary
- Conditions
- Cancer of the Pancreas
- Pancreas Adenocarcinoma
- Pancreas Cancer
- Type
- Interventional
- Phase
- Phase 2
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04331041
- Collaborators
- National Cancer Institute (NCI)
- Verastem, Inc.
- Investigators
- Principal Investigator: Hyun Kim, M.D. Washington University School of Medicine